de Vries L, Bulvik S, Phillip M
Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel.
Arch Dis Child. 2009 Jan;94(1):33-7. doi: 10.1136/adc.2007.134841. Epub 2008 Aug 14.
To investigate the clinical manifestations of autoimmune thyroiditis (AIT) leading to referral in children and adolescents, in addition to disease course and long-term outcome.
Chart review.
Major tertiary hospital.
114 children/adolescents (92 female, 22 male; mean (SD) age 11.8 (35) years) with AIT referred for evaluation/treatment.
Clinical characteristics at presentation, reasons for referral, treatment and long-term (mean 6 years) outcome; by thyroid and pubertal status.
The male/female (1:4.2) ratio was lower than in adult AIT (1:10) and varied by age. Patients with noticeable goitre at presentation (39.5%) accounted for half the total number in whom goitre was eventually diagnosed. Other reasons for referral were clinical symptoms of hypothyroidism (28.9%) and findings on work-up for an unrelated problem (19.2%) or for high-risk groups (10.5%). There was no difference in management or outcome between patients who underwent ultrasound (n = 79) or not. Treatment was initiated shortly after diagnosis in all 42 hypothyroid patients and 44/48 compensated hypothyroid patients, and within 16 months in 19/24 euthyroid patients. There was no change in thyroid status in the nine untreated patients. Height standard deviation score (SDS) was normal at referral and last visit and correlated with parental height SDS. Puberty was normal. There was no significant difference in body mass index SDS at referral by pubertal or thyroid status. There was no difference from the general population in the prevalence of obesity.
Although goitre is the main symptom leading to diagnosis of AIT, it is still often overlooked, underscoring the need for thorough thyroid evaluation on routine physical examination. Acquired hypothyroidism is not often associated with obesity, and ultrasound usually has no added diagnostic value. Adequate treatment in this age group leads to normal growth, puberty and final height.
除了疾病病程和长期预后外,调查导致儿童和青少年被转诊的自身免疫性甲状腺炎(AIT)的临床表现。
病历回顾。
大型三级医院。
114例因AIT前来评估/治疗的儿童/青少年(92例女性,22例男性;平均(标准差)年龄11.8(3.5)岁)。
就诊时的临床特征、转诊原因、治疗及长期(平均6年)预后;按甲状腺和青春期状态分类。
男/女比例(1:4.2)低于成人AIT(1:10),且随年龄而异。就诊时有明显甲状腺肿大的患者(39.5%)占最终确诊甲状腺肿大患者总数的一半。其他转诊原因包括甲状腺功能减退的临床症状(28.9%)、因无关问题检查(19.2%)或高危人群检查(10.5%)时的发现。接受超声检查(n = 79)和未接受超声检查的患者在治疗和预后方面无差异。所有42例甲状腺功能减退患者和44/48例代偿性甲状腺功能减退患者在诊断后不久开始治疗,19/24例甲状腺功能正常患者在16个月内开始治疗。9例未治疗患者的甲状腺状态无变化。身高标准差评分(SDS)在转诊时和末次就诊时正常,且与父母身高SDS相关。青春期正常。按青春期或甲状腺状态分类,转诊时体重指数SDS无显著差异。肥胖患病率与一般人群无差异。
虽然甲状腺肿大是导致AIT诊断的主要症状,但仍常被忽视,这突出了在常规体格检查中对甲状腺进行全面评估的必要性。获得性甲状腺功能减退通常与肥胖无关,超声检查通常没有额外的诊断价值。该年龄组的充分治疗可使生长、青春期发育和最终身高正常。